Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 2/20 | 0.46 |
| ▸ | CES1 | P23141 | 1/20 | 0.44 |
| ▸ | MLYCD | O95822 | 10/20 | 0.42 |
| ▸ | PLA2G2D | Q9UNK4 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3786793 | 0.87 | ACHE (0.45) | ACHECES1MLYCDPLA2G2D | |
| SCHEMBL29952929 | 0.79 | ACHE (0.44) | ACHECES1MLYCD | |
| SCHEMBL3789857 | 0.76 | CES1 (0.45) | ACHECES1MLYCDPLA2G2D | |
| SCHEMBL1275130 | 0.75 | CES1 (0.48) | ACHECES1PLA2G2D | |
| SCHEMBL3714923 | 0.74 | RXRB (0.53) | ACHECES1MLYCDPLA2G2D | |
| SCHEMBL28674119 | 0.72 | KDM4E (0.50) | — | |
| SCHEMBL1046198 | 0.72 | CES1 (0.56) | CES1MLYCD | |
| SCHEMBL3787503 | 0.72 | MGLL (0.41) | ACHECES1PLA2G2D | |
| SCHEMBL3789805 | 0.72 | CES1 (0.45) | ACHECES1MLYCDPLA2G2D | |
| SCHEMBL6740754 | 0.71 | MAPT (0.38) | ACHECES1PLA2G2D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100087680-A1 | METHOD FOR PRODUCING BIARYL COMPOUND | SUMITOMO CHEMICAL COMPANY LIMITED (JP) | 2010-04-08 | — | — | US | disclosed |
| EP-1914221-A1 | PROCESS FOR PRODUCING BIARYL COMPOUND | Sumitomo Chemical Company, Limited (JP) | 2008-04-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100087680-A1 | METHOD FOR PRODUCING BIARYL COMPOUND | NISCH, BLVRB, BBOX1 | ACHE 295/4885CES1 4009/4885MLYCD 1722/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.